[Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence]
- PMID: 36695893
- PMCID: PMC9875188
- DOI: 10.1007/s00115-022-01431-x
[Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence]
Abstract
Over the past 5 years both media and scientific interest has surged regarding the disorder myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS), not least because of the clinically similar manifestation in long COVID or post-COVID. In this review we discuss the process of clinical diagnosis and randomized controlled therapeutic studies on ME/CFS, and the similarities or differences to long COVID and post-COVID. So far, neither clear pathophysiologically causal nor therapeutic evidence-based results on ME/CFS have been identified in the many years of scientific research. Given the evident psychiatric comorbidity rates in patients with a diagnosis of ME/CFS, a psychosomatic etiology of this syndrome should be considered. Furthermore, a precise and reliable diagnostic classification based on stricter criteria would benefit both pathophysiological and therapeutic research.
In den vergangenen 5 Jahren hat sowohl das mediale als auch das wissenschaftliche Interesse an der Erkrankung myalgische Enzephalomyelitis/„chronic fatigue syndrome“ (ME/CFS) signifikant zugenommen; nicht zuletzt auch durch die klinisch ähnliche Manifestation im Rahmen von Long- oder Post-COVID. In dieser Übersichtsarbeit diskutieren wir die klinische Diagnosestellung und therapeutische Studien zu ME/CFS sowie die Gemeinsamkeiten oder Unterschiede zu Long‑/Post-COVID. Bisher liegen weder pathophysiologisch eindeutig kausale noch therapeutisch evidenzbasierte Ergebnisse in der langjährigen wissenschaftlichen Forschung zu ME/CFS vor. Nicht zuletzt aufgrund der relevanten psychiatrischen Komorbiditätsrate beim ME/CFS ist nach der aktuellen Datenlage eine psychosomatische Ätiologie der Erkrankung zu diskutieren. Des Weiteren könnte sich eine genauere und sichere Diagnosestellung anhand strikterer Diagnosekriterien auf die weitere Forschung und vor allem hinsichtlich Therapien positiv auswirken.
Keywords: Evidence; POTS; Post-COVID; Psychosomatic; Randomized-controlled trials.
© 2023. The Author(s).
Similar articles
-
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection?Curr Med Res Opin. 2023 Aug;39(8):1119-1126. doi: 10.1080/03007995.2023.2242244. Epub 2023 Aug 4. Curr Med Res Opin. 2023. PMID: 37501626
-
Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Mayo Clin Proc. 2023 Oct;98(10):1544-1551. doi: 10.1016/j.mayocp.2023.07.032. Mayo Clin Proc. 2023. PMID: 37793728 Review.
-
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).Trials. 2024 Mar 7;25(1):172. doi: 10.1186/s13063-024-07982-5. Trials. 2024. PMID: 38454468 Free PMC article.
-
Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Medicina (Kaunas). 2021 Dec 24;58(1):28. doi: 10.3390/medicina58010028. Medicina (Kaunas). 2021. PMID: 35056336 Free PMC article.
-
Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. Rev Environ Health. 2015. PMID: 26613325 Review.
Cited by
-
[Validation of subjective complaints: differential diagnosis of "healthy suffering" using fatigue as an example].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Nov;67(11):1264-1272. doi: 10.1007/s00103-024-03963-w. Epub 2024 Oct 14. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 39400559 Free PMC article. Review. German.
-
The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Medicina (Kaunas). 2023 Apr 6;59(4):719. doi: 10.3390/medicina59040719. Medicina (Kaunas). 2023. PMID: 37109676 Free PMC article.
-
Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients.Medicina (Kaunas). 2023 Dec 31;60(1):83. doi: 10.3390/medicina60010083. Medicina (Kaunas). 2023. PMID: 38256344 Free PMC article.
-
[Burnout : Symptoms, diagnostics and treatment approaches].Nervenarzt. 2024 May;95(5):484-493. doi: 10.1007/s00115-024-01649-x. Epub 2024 Apr 16. Nervenarzt. 2024. PMID: 38625570 Review. German.
-
Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.Eur J Med Res. 2024 Mar 1;29(1):148. doi: 10.1186/s40001-024-01747-1. Eur J Med Res. 2024. PMID: 38429822 Free PMC article. Review.
References
-
- [Ng206] NG . Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. 2021. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous